This page summarizes upcoming deadlines related to DAIDS requirements and new initiatives for clinical research sites. For more information about specific requirements, please contact your OCSO Program Officer.
Clinical Trials Units have additional requirements related to grants reporting. For grant-related deadlines, please reference the NIH Grants & Funding site.
DAIDS, as a Sponsor, is responsible for oversight of Quality Management activities at DAIDS-sponsored and/or supported sites, so that we may be in compliance with the FDA Code of Federal Regulations (CFR) and the International Council for Harmonization (ICH) E6 (R2).
Please note that according to the Quality Management section in the DAIDS SCORE Manual, all DAIDS sponsored and/supported sites are required to report a summary of Quality Assurance (QA) activities to their DAIDS Program Officer using the DAIDS CQMP CRS QA Summary Report template bi-annually on June 1st and December 1st.